We report here a fully automated, end-to-end, integrated continuous manufacturing process for a small-molecule generic medication with built-in quality assurance. The entire process fits into a box of 30.7 m2 modular footprint and a total residence time of less than 30 h, with a throughput up to 40.3 × 106 tablets per year.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c9cc06945c | DOI Listing |
Publication Analysis
Top Keywords
automated modular
4
modular assembly
4
assembly drugs
4
drugs miniaturized
4
miniaturized plant
4
plant report
4
report fully
4
fully automated
4
automated end-to-end
4
end-to-end integrated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!